Clinical trials
Terminated Graft vs Host Disease trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
72 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 4 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 4 |
| 2007 | 7 |
| 2008 | 6 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 7 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 5 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 72 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 7 |
| Vanderbilt-Ingram Cancer Center | 4 |
| Fred Hutchinson Cancer Center | 3 |
| Masonic Cancer Center, University of Minnesota | 3 |
| National Heart, Lung, and Blood Institute (NHLBI) | 3 |
| Baxalta now part of Shire | 2 |
| Dana-Farber Cancer Institute | 2 |
| H. Lee Moffitt Cancer Center and Research Institute | 2 |
| Incyte Corporation | 2 |
| Kiadis Pharma | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Graft vs Host Disease | 72 |
| Myelodysplastic Syndromes | 20 |
| Leukemia | 19 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 19 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 17 |
| Lymphoma | 17 |
| Multiple Myeloma | 16 |
| Leukemia, Myeloid, Accelerated Phase | 14 |
| Leukemia, Myeloid, Acute | 14 |
| Lymphoma, Mantle-Cell | 14 |
Trials
Showing 1 to 25 of 72. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.